Will Turn Bio be the first longevity company to take cell rejuvenation to the clinic?
Author: LT Staff | Published on: October 25, 2023
Cell rejuvenation company Turn Biotechnologies has reported receiving positive feedback during an FDA INTERACT meeting to review the company’s therapeutic treatment to rejuvenate skin cells. The company, which is developing mRNA medicines for a range of age-related conditions, said that the meeting focused on its progress and plans for TRN-001, a treatment designed to repair damaged skin at the cellular level.
Turn Bio says its preclinical results demonstrate that TRN-001 improves skin integrity, reduces inflammation and cell senescence and achieves hair follicle transfection. If the therapy goes on to work in humans, the company claims it would be the first treatment to repair skin damage at a cellular level, restoring follicles’ ability to grow hair.
Powers wrote: ↑Thu Nov 02, 2023 2:13 am
Sounds clickbaity tbh.
I wouldn't quite say it is clickbaity. A moderate amount of hyperbole on the part of the writer, perhaps. I didn't care about any of that. It was the things Dr. Sinclair said between the interjections by the writer that inspired me. Dr. Sinclair isn't known to make statements he cannot support. It was enough to encourage Peter H. Diamandis, who was talking to Dr. Sinclair in this Abundance 360 interview, to rouse the audience in the room into an applause.
To know is essentially the same as not knowing. The only thing that occurs is the rearrangement of atoms in your brain.
